Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report
• Underlying EBITA fell to $734 million from $823 million, and the underlying EBITAMargineased to 6.1% from 6.8%.
•Earningsbefore interest, tax,DepreciationandAmortisation(EBITDA) were $226.0 million, up 42.9 per cent, at aMarginof 7.58 per cent.
• Life Sciences covers food, pharmaceutical, environmental and related testing, and accounted for about 61 per cent of groupRevenuein FY26.
• A separate temporary supplemental tax, previously expected to end in 2026, would be extended at a lower take.
• Reported net profit after tax was $92.4 million, down 5.2%, while profit before tax was $123.0 million.
• Yet group EBIT was a loss of $125.2 million, compared with a profit of $113.4 million a year earlier, and the statutory net result was a loss of $53.6 million, against a profit of $89.7 million.
• Underlying net profit after tax was $433 million, up 24%, while statutory net profit was $362 million, up 19%.
• Net profit after tax was $802 million, up 857 per cent on FY25, and underlying EBIT was $1,273.4 million.
• For the year ended 30 June 2026, Brambles reported group sales revenue of US$7,043 million, up 2% at constant currency and 6% at actual exchange rates.
• The company said the proposal implied anEnterprise valueof about A$9.4 billion and a 32.1% premium to the A$2.37 close on 12 August 2026.
Please wait processing your request...
You are not subscribed for this report, Want to See?
One of our sales representative will contact you soon!
Welcome to Kalkine!
Start Your 7-Days Free Trial Today!
Hi! How can we help you today?
Loading…